Open AccessZiprasidone Vs Olanzapine in Recent-Onset Schizophrenia and Schizoaffective Disorder: Results of an 8-Week Double-Blind Randomized Controlled Trial
Author(s) -
Koen P. Grootens,
N.M.J. van Veelen,
J. Peuskens,
Bernard Sabbe,
É. Thys,
Jan K. Buitelaar,
Robbert J. Verkes,
René S. Kahn
Publication year - 2009
Publication title -
schizophrenia bulletin
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.823
H-Index - 190
eISSN - 1745-1701
pISSN - 0586-7614
DOI - 10.1093/schbul/sbp037
Subject(s) - ziprasidone , olanzapine , tolerability , extrapyramidal symptoms , schizoaffective disorder , positive and negative syndrome scale , psychology , medicine , schizophreniform disorder , clinical global impression , antipsychotic , haloperidol , schizophrenia (object oriented programming) , psychiatry , psychosis , adverse effect , placebo , dopamine , alternative medicine , pathology
Head-to-head comparisons of antipsychotics have predominantly included patients with chronic conditions. The aim of the present study was to compare the efficacy and tolerability of ziprasidone and olanzapine in patients with recent-onset schizophrenia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom